跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96 条关于
“Mihael Polymeropoulos”
全部
96
临床试验
11
药物
10
机构
39
资讯
36
去年
Vanda Pharmaceuticals' VGT-1849A, a Selective JAK2 Inhibitor, Receives FDA Orphan Drug Designation for Polycythemia Vera
去年
Vanda Pharmaceuticals Navigates Hetlioz Sales Decline with Expansion Efforts
去年
Vanda Acquires Global Rights to Imsidolimab for GPP in $50 Million Deal with AnaptysBio
9个月前
FDA Lifts Clinical Hold on Tradipitant, Clearing Path for First New Motion Sickness Treatment in 40 Years
去年
Vanda Pharmaceuticals Battles FDA Over Gastroparesis Drug Hearing Delays
去年
Vanda Pharmaceuticals Reports Strong Q2 2025 Results with Multiple Drug Applications Under FDA Review
9个月前
Vanda Pharmaceuticals Submits BLA for Imsidolimab to Treat Rare Generalized Pustular Psoriasis
10个月前
Vanda's Tradipitant Reduces GLP-1 Induced Vomiting by 50% in Phase 2 Trial
去年
Vanda Pharmaceuticals Reports Revenue Increase and Advances Pipeline in Q3 2024
5个月前
Vanda Pharmaceuticals Initiates Thetis Trial Testing NEREUS for GLP-1 Receptor Agonist-Induced Vomiting
第 1 页,共 4 页
上一页
下一页